Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.